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useful for an independent verification of dosimetric data and 
tables used for manual calculations. 
These results also highlight the need for a better 
understanding of dose distributions associated with irregular 
and curved surfaces, through numerical modelling such as 
Monte Carlo calculations. Further investigation is thus 
necessary to understand these effects and to improve target 
coverage in pelvic IOERT. 
1. Ciocca M, Piazzi V, Lazzari R, et al. Real-time in vivo 
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Purpose/Objective: Design and dosimetry characteristics of a 
commercial applicator system for intraoperative radiation 
therapy (IORT) utilizing ELEKTA Precise accelerator have 
been previously reported. The system is geometrically more 
complex than the standard electron applicators used for 
external beam therapy. Moreover, the geometry is different 
from the reference conditions used in various dosimetry 
protocols. The purpose of this work is to validate the 
measured dosimetry data by Monte Carlo (MC) simulations. 
Materials and Methods: An IORT hard-docking commercial 
system (Arplay Medical) includes PMMA cones with different 
diameters and a set of secondary lead collimators. The 
telescopic device allows changing of source to surface 
distance (SSD). The inner diameters of the available cones 
are 40, 50, 60 and 80 mm. 6, 9 and 12 MeV beams from 
Elekta Precise linac are used for IORT treatments. The 
EGSnrc code package was used for MC simulation. First, the 
incident electron beam parameters (energy spectrum, FWHM) 
were adjusted to match the measured data (depth doses and 
profiles) at SSD=100 cm for 14x14 standard electron 
applicator. These parameters were then used to calculate 
depth doses, dose profiles and output factors with the IORT 
applicator system. BEAMnrc code was used to generate the 
phase-space file in a plane at the IORT cone end. This file 
was used in DOSXYZnrc code to calculate PDDs, profiles and 
output in a water phantom at SSD= 100 cm for each 
combination of cone diameter and beam energy. MC 
calculations were compared with the available set of 
measurements used in clinical practice. 
Results: The results of our Monte Carlo calculations were 
found to be in general agreement with the measurements, 
providing a promising tool for further studies of dose 
distribution calculations in IORT. For all combinations of 
energy and cone diameter, the calculated depth doses were 
within 2%/1mm agreement with the measurements and 
calculated profiles were within 3%/1mm agreement with the 
measurements. Calculated output factors were within 3% 
agreement with the measurements. 
Conclusions: The measured dosimetry data used for IORT 
calculations have been validated by MC simulations. This 
work also indicates that simulations can complement and/or 
replace experimental measurements for design improvements 
of an IORT system.  
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Purpose/Objective: Rectal cancer is the second most 
frequently treated tumour with intra-operative radiation 
therapy (IOERT) in Europe1 , the first being breast cancer. 
Due to the complex anatomy of the pelvic region, 
understanding the IOERT dose distribution is particularly 
challenging. This work was prompted by a preliminary 
attempt to perform and to interpret in vivo measurements, 
and aims to shed some light on how the irradiation geometry 
affects the dose distribution in pelvic IOERT. 
Materials and Methods: To determine the effect of irregular 
geometries on the dose distribution, a methodology using 
Gafchromic EBT3 films for 2D dose distributions 
determination, parallel to the incident beam was validated 
through comparison with water phantom measurements. 
Data of anatomical region irradiated, applicator diameter 
and bevel angle was obtained from 21 pelvic IOERT 
procedures. This data was combined with anatomical models 
and photographs taken during in vivo measurements. 
Schematic models were made of the more frequent 
irradiation scenarios in pelvic IOERT, and relevant phantom 
equivalents were constructed. The corresponding dose 
distributions were obtained, and compared to those in 
conventional irradiation geometry (flat surface, parallel to 
applicator bevel).  
Results: The most frequently used bevel angle is 45°. A 
curved (concave) irradiation surface is frequent in pelvic 
IOERT. Haematic fluid build-up is also problematic in this 
area. Applicator positioning can be challenging when none of 
the available applicators is an ideal fit for the surface to be 
irradiated. This results in air gaps caused by non-parallel 
alignment of surface and applicator edges. Additionally, the 
surface to be irradiated may have irregularities in contour as 
well.  
Concave irradiation surfaces affect the dose distribution, 
relative to the one obtained in water. Air gaps due to non 
parallel alignment of the applicator seem to have little 
influence, although the effect of a different angle of 
incidence is clearly visible. Irregularities in contour may 
create hotspots nearby, as shown by the arrow in Figure 1.  
 
Conclusions: Dose distributions in pelvic IOERT are complex, 
non-homogeneous and hard to predict. The constructed 
phantom models allow us to simulate dose distributions, with 
good visualization of the clinically relevant effects, but with 
a controlled geometry. The results obtained confirm that 
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irregular and curved surfaces can significantly alter the dose 
distribution. A better understanding of these effects is 
necessary to assess target coverage in pelvic IOERT, and 
interpret any in vivo measurements. 
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Purpose/Objective: The aim was to evaluate whether prone 
position on a belly board for rectal cancer radiotherapy is 
still beneficial when highly-conformal volumetric modulated 
arc therapy (VMAT) is applied. Additionally, the feasibility of 
moderate dose escalation with VMAT was investigated. 
Materials and Methods: Eleven patients with stage II/III 
rectal cancer were prospectively enrolled. Each patient 
underwent a planning CT in both prone and supine position. 
For prone positioning, a belly board was used (MacroMedics® 
Pelvic Prone BoardTM).  
To evaluate the dosimetrical benefit of prone vs. supine 
position, VMAT plans (2 arcs of 358°) were created for both 
treatment positions. A dose of 45 Gy in 25 fractions was 
prescribed. Plans were considered acceptable if ≥95% of the 
planning target volume (PTV) received ≥95% of the prescribed 
dose and if Dmax was ≤107% of the prescribed dose. For 
comparison of prone and supine, an average DVH over all 
patients was created by calculating for each structure the 
mean relative volume in 10 cGy absolute dose bins.  
To investigate the feasibility of moderate dose escalation, 
only the prone scans were used and 3D-conformal 
radiotherapy (3D-CRT) plans (45 Gy in fractions of 1.8 Gy) 
were compared with VMAT plans (50 Gy in fractions of 2 Gy). 
The homogeneity index (HI) of the PTV was defined as [(D2-
D98)/Dprescribed x 100] and the conformity index (CI) as 
V95/PTVvolume. Statistical analyses were performed using the 
Wilcoxon signed-rank test; a p-value ≤ 0.05 was considered 
statistically significant.  
Results: While the PTV parameters were similar, prone 
positioning reduced the V15 of the small bowel (median 64.4 
cc vs. 194.8 cc; p = 0.008), the V15 of the large bowel 
(median 38.5 cc vs. 71.3 cc; p = 0.006) and the V15 of the 
bowel bag (median 433.4 cc vs. 762.2 cc; p = 0.003) 
compared to supine using VMAT (Table 1). The V45 of all 
bowel structures was also lower in prone position, but this 
was not statistically significant. 
Moderate VMAT dose escalation up to 50 Gy does not lead to 
an increased dose to the organs at risk compared to 3D-CRT 
up to 45 Gy. The V15 of the bowel bag and the V40 of the 
bladder were significantly lower with VMAT 50 Gy compared 
to 3D-CRT 45 Gy (median 445.2 cc vs. 562.6 cc, p = 0.003; 
median 32.8 cc vs 47.1 cc; p = 0.003 respectively). 3D-CRT 
plans had a higher CI compared to VMAT (median 1.00 vs. 
0.96; p = 0.003). The PTV dose homogeneity was better in 
the 3D-CRT plans compared to the VMAT plans (median 8.13 
vs. 9.48; p = 0.006).  
 
 
 
Conclusions: Even with highly-conformal radiotherapy 
techniques as VMAT, prone position with belly board remains 
beneficial for the dose to the bowel structures. Moderate 
dose escalation with VMAT up to 50 Gy does not increase the 
V15 and V45 of the bowel structures compared to 3D-CRT up 
to 45 Gy.  
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Purpose/Objective: To quantify and to assess the dosimetric 
significance of rotational displacements in head and neck 
patients planned with VMAT, in order to establish a process 
development pathway for the management of rotational 
displacements. 
Materials and Methods: Initial quality assurance of the 
commercially available IGRT software (OBITM) was performed. 
Varying permutations of the offline auto match process and 
weightings (Volume of Interest (VOI), Structure VOI (sVOI) 
and Intensity Range) were assessed in Six degrees of freedom 
(6DoF), in order to determine the optimum method for 
rotational quantification across twelve patients with various 
tumour sites. To determine thresholds of dosimetric impact 
for rotational setup errors, simulated rotational 
displacements were created on the Planning CT images (PCT) 
for each patient. Using commercially available software 
(MIMS TM) the PCT images were rotated around the isocentre 
incrementally from 1 to 5 degrees – this was done for 
combined and single axis rotational displacements. The 
manipulated image sets were then exported back to the 
ECLIPSETM treatment planning system to determine the 
dosimetric consequences of rotations on both the PTV and 
the Organs At Risk (OAR). 
Results: Regardless of Intensity Range employed, results 
demonstrate that using PTV as the sVOI is preferential 
compared to using OAR sVOI or matching without the 
inclusion of rotations (Table 1). On the virtually rotated PCT 
images, both combined and single axis simulations 
demonstrated more variance in dose to the OAR when 
compared with PTV. D98% for the PTV showed noticeable 
difference when compared to the PCT, varying by 11.3% and 
13.3% for combined rotations of +3 and -3 degrees, 
respectively. D2% for the PTV showed little or no variation 
(Figure 1A). Spinal Cord Planning Organ at Risk Volume (PRV) 
(3mm margin) showed the most noticeable dose difference 
with D1cc variation of 15.54% and 12.65% at combined 
rotations of +/-1 degree, respectively. Spinal cord (SC) is 
